HUTCHMED completes enrollment of global Phase III SAFFRON trial for ORPATHYS and TAGRISSO combination in lung cancer

iLeukon reports FDA clearance of IND application for phase II study of ILKN421H in advanced NSCLC

AVEO Oncology signs development and option agreement with HiberCell

Merck secures USD700m R&D funding from Blackstone Life Sciences for cancer drug sacituzumab tirumotecan

Fusion Antibodies validates OptiMAL platform for peptide targets ahead of December 2025 launch

Roquefort Therapeutics out-licenses MK Cell program and extends Lyramid sale deadline

Servier's VORANIGO (vorasidenib) receives Prix Galien USA Award

Akeso's ivonescimab in combination with chemotherapy granted Breakthrough Therapy Designation in China

Pilatus Biosciences to present new preclinical data on PLT012 at SITC 2025

Cellipont Bioservices and Ernexa Therapeutics form cell therapy partnership

Curasight advances Phase 2 prostate cancer trial with Curium partnership

European Commission approves Merck's KEYTRUDA (pembrolizumab) for resectable head and neck cancer expressing PD-L1

Rx to Go receives ACHC re-accreditation for pharmacy services

San Luis Obispo Family Dentist Publishes 'A Parent's Quick Guide to Family Dentistry'

BioDlink makes first international shipment of bevacizumab to Colombia